Eli Lilly expects FDA approval of Zepbound for sleep apnea in the near futureBy businessinvestopedia.comJune 21, 20240 Eli Lilly The company said Friday it has filed for U.S. approval of its weight-loss drug Zepbound to treat the…
FDA adviser recommends Eli Lilly’s Alzheimer’s drug donanemabBy businessinvestopedia.comJune 10, 20240 Eli Lilly headquarters in Indianapolis, Indiana, US, Wednesday, May 3, 2023. Eli Lilly shares rose at the open on Wednesday…
